Lichenoid graft vs. host disease following liver transplantation

Journal of Cutaneous Pathology

Volumn 31, Issue 2, 2004, Pages 179-184

  Walling, Hobart W ^a   Volgt, Michael D ^a   Stone, Mary Seabury ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CORTICOSTEROID; COTRIMOXAZOLE; EMOLLIENT AGENT; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THIAZIDE DIURETIC AGENT; TRIMETHOPRIM;

ADULT; ANAMNESIS; ARTICLE; BLOOD; CASE REPORT; CHIMERA; DIAGNOSTIC PROCEDURE; DRUG ERUPTION; DYSGEUSIA; EOSINOPHIL; FASCIITIS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFUSION; LICHENOID ERUPTION; LIVER DISEASE; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PRURITUS; SALVAGE THERAPY; SKIN BIOPSY; TREATMENT OUTCOME;

BIOPSY; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; KERATOSIS; LICHENOID ERUPTIONS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 1642480905     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00146.x     Document Type: Article

References (36)

1. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
2. Pageaux GP, Perrigault PF, Fabre JM, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995; 9: 65.
3. Au WY, Ma SK, Kwong YL, et al. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing. Clin Transplant 2000; 14: 174.
4. Arrieta A, Maruri N, Rinon M, Fernandex JR, Ortiz de Urbina J, Garcia Masdevall MD. Confirmation of graft-versus-host disease by HLA typing after liver transplantation. Transplant Proc 2002; 34: 278.
5. Farmer ER. Human cutaneous graft-versus-host-disease. J Invest Dermatol 1985; 85 (Suppl.): 124S.
6. Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol 1998; 134: 602.
7. Connors J, Drolet B, Walsh J, Crosby DL, Esterly NB. Morbilliform eruption in a liver transplantation patient. Arch Dermatol 1996; 132: 1161.
8. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host- disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267.
9. Johnson MT, Farmer ER. Graft-versus-host reactions in dermatology. J Am Acad Dermatol 1998; 38: 369.
10. Andrews ML, Robertson I, Weedon D. Cutaneous manifestations of chronic graft-versus-host-disease. Australas J Dermatol 1997; 58: 53.
11. Horn TD, Zahurak ML, Atkins D, Solomon AR, Vogelsang GB. Lichen planus-like histopathologic characteristics in the cutaneous graft-versus-host reaction. Arch Dermatol 1997; 133: 961.
12. Horn TD, Redd JV, Karp JE, Beschorner WE, Burke PJ, Hood AF. Cutaneous eruptions of lymphocyte recovery. Arch Dermatol 1989; 125: 1512.
13. Bauer DJ, Hood AF, Horn TD. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery. Arch Dermatol 1993; 129: 855.
14. Horn TD. Acute cutaneous eruptions after marrow ablation: Roses by other names? J Cutan Pathol 1994; 21: 385.
15. Scott GA. Report of three cases of cutaneous reactions to granulocyte macrophage-colony-stimulating factor and a review of the literature. Am J Dermatopathol 1995; 17: 107.
16. Volc Platzer B, Rappersberger K, Mosberger I, et al. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation. J Invest Dermatol 1988; 91: 162.
17. Roberts JP, Ascher NL, Lake J, et al. Graft vs host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14: 274.
18. Collins RH, Anastasi J, Terstappen LW, et al. Brief report: donor-derived long-term multilineage hematopoiesis in a liver transplant recipient. N Eng J Med 1993; 328: 762.
19. Redondo P, Espana A, Herrero JI, et al. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993; 29: 314.
20. Burt M, Jazwinska E, Lynch S, et al. Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient. Liver Transpl Surg 1996; 2: 391.
21. Sanchez-Izquierdo JA, Lumbreras C, Colina F, et al. Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review. Hepatogastroenterology 1996; 43: 1057.
22. Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transplant 2000; 6: 180.
23. Kashiwagi N, Porter KA, Penn I, Brettschneider L, Starzl TE. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum 1969; 20: 374.
24. Hove WR, van Hoek B, Bajema IM, Ringers J, van Krieken JH, Lagaaij EL. Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytes. Liver Transpl 2003; 9: 552.
25. Starzl TE, Demetris AJ, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
26. Jamieson NV, Joysey V, Friend PJ, et al. Graft-versus-host disease in solid organ transplantation. Transplant Int 1991; 4: 67.
27. Elwood ET, Larsen CP, Maurer DH, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997; 349: 1358.
28. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
29. Pham SM, Rao AS, Zeevi A, et al. A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 2000; 119: t-81.
30. Vogelsang GB, Arai S. Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings. Bone Marrow Transplant 2001; 27: 1255.
31. Vogelsang GB. How I treat chronic graft-versus-host disease. Blood 2001; 97: 1196.
32. Lehner F, Becker T, Sybrecht L, et al. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression. Transplantation 2002; 73: 307.
33. Volc-Platzer B, Honingsmann H, Hinterberger W, Wolff K. Photochemotherapy improves chronic cutaneous graft-versus host disease. J Am Acad Dermatol 1990; 23: 220.
34. Jampel RM, Farmer ER, Vogelsang GB, Wingard J, Santos GW, Morison WL. PUVA therapy for chronic cutaneous graft-versus host disease. Arch Dermatol 1991; 127: 1673.
35. Enk CD, Elad S, Vexler A, Kapelushnik J, Gorodetsky R, Kirschbaum M. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant 1998; 22: 1179.
36. Vogelsang GB, Farmer ER, Hess AD, et al. Thalidomide for treatment of chronic graft versus host disease. N Engl J Med 1992; 326: 1055.